Primary staging Primary staging in rectal cancer is essential for determining the optimal treatment strategy and consists of local staging and screening for distant metastases. Local staging is important to determine the surgical approach and to identify individual risk factors for recurrence, such as depth of extramural spread, lymph node involvement, mesorectal fascia (MRF) involvement and extramural vascular invasion [1–4]. Patients with a low risk for recurrence can be treated by surgery alone, whereas patients with a high risk for recurrence must be treated with neoadjuvant (chemo-) radio-therapy (CTxRTx) to decrease the chance of local recurrence [5,6]. Screening for distant metastases is important to identify metastasized patients who require a different treatment approach. Patients with resectable synchronous distant metastases should be treated with curative intent by resection of the distant metastases and primary tumor. Patients with unresectable distant metastases can be safely spared rectal surgery and treated with systemic chemotherapy, with a low chance of emergency surgery [7]. For primary local staging, MRI is superior compared with other imaging modalities currently available. Accuracies of tumor staging, nodal staging and MRF involvement by MRI are higher compared with the accuracies of CT scans and endoscopic ultrasound sonography [8–10]. Moreover, the multicenter Mercury study, with 12 colorectal units in four European countries, showed MRI to be highly accurate and reproducible [11]. Therefore, MRI is recommended in all guidelines as the preferred imaging modality in the preoperative assessment of rectal cancer [12–14]. For screening for distant metastases, most guidelines advise a thoracoabdominal CT scan [12,14].